The Potential Rise in the Price of Cadrenal Therapeutics Inc. (CVKD) following insiders activity


Cadrenal Therapeutics Inc.’s recently made public that its Director MURPHY JOHN RAYMOND acquired Company’s shares for reported $13900.0 on Mar 21. In the deal valued at $1.39 per share,10,000 shares were bought. As a result of this transaction, MURPHY JOHN RAYMOND now holds 594,792 shares worth roughly $ 0.53 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, MURPHY JOHN RAYMOND bought 20,000 shares, generating $33,398 in total proceeds. Upon buying the shares at $1.67, the Director now owns 574,792 shares.

Price Performance Review of CVKD

On Friday, Cadrenal Therapeutics Inc. [NASDAQ:CVKD] saw its stock jump 15.71% to $0.89. On the same session, the stock had its day’s lowest price of $0.745, but rose to a high of $0.96. Over the last five days, the stock has gained 25.30%. Cadrenal Therapeutics Inc. shares have fallen nearly -78.37% since the year began. A total of 0.19 million shares were traded, compared to the trading of 95100.0 shares in the previous session.

Levels Of Support And Resistance For CVKD Stock

The 24-hour chart illustrates a support level at 0.7707, which if violated will result in even more drops to 0.6503. On the upside, there is a resistance level at 0.9857. A further resistance level may holdings at 1.0803. The Relative Strength Index (RSI) on the 14-day chart is 53.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0417, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.08%. Stochastics %K at 67.69% indicates the stock is a holding.

How much short interest is there in Cadrenal Therapeutics Inc.?

A steep rise in short interest was recorded in Cadrenal Therapeutics Inc. stocks on Aug 14, 2023, dropping by -0.38 million shares to a total of 49100.0 shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.43 million shares. There was a decline of -777.39%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.89% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.33.


Please enter your comment!
Please enter your name here